Elastomeric Infusion Pumps Market Report 2026

Elastomeric Infusion Pumps Market Overview

• Elastomeric Infusion Pumps market size has reached to $1.16 billion in 2025 • Expected to grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Rising Hospitalization Rates Drives Growth In The Elastomeric Infusion Pumps Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Elastomeric Infusion Pumps Market?

Elastomeric infusion pumps are medical devices used for the controlled delivery of medications or fluids over a set period. These pumps are known for their simplicity, portability, and ease of use, making them particularly valuable in both hospital and home care settings. They allow patients to receive treatment outside of a clinical setting, enabling mobility and flexibility while undergoing infusion therapy. The main types of elastomeric infusion pump products are continuous-rate elastomeric pumps and variable-rate elastomeric pumps. Variable-rate elastomeric pumps enable healthcare providers to adjust medication infusion rates by modifying the elastomeric balloon’s pressure or using different flow restrictors, which ensure tailored treatment according to individual patient needs. It is used in various treatments, such as pain management, antibiotics or antivirals, chemotherapy, and others, through various end-users, including hospitals, ambulatory surgical centers, home care settings, clinics, and others.

What Is The Elastomeric Infusion Pumps Market Growth Forecast?

The elastomeric infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing preference for homecare treatment models, rising demand for chemotherapy outside hospital settings, growth in ambulatory surgical centers, increasing healthcare focus on patient mobility and comfort, rising healthcare expenditure on infusion therapies. Major trends in the forecast period include rising adoption of home-based infusion therapy, growing preference for portable and disposable pumps, increasing use in pain management treatments, shift toward outpatient and ambulatory care infusions, rising demand for simplified drug delivery devices.

Global Elastomeric Infusion Pumps Market Segmentation

1) By Product Type: Continuous Rate Elastomeric Pumps, Variable Rate Elastomeric Pumps 2) By Treatment: Pain Management, Antibiotic Or Antiviral, Chemotherapy, Other Treatments 3) By End-User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, Other End-Users Subsegments: 1) By Continuous Rate Elastomeric Pumps: Single-Flow Rate Elastomeric Pumps, Multi-Flow Rate Elastomeric Pumps (Fixed), Infusion Pumps For Pain Management 2) By Variable Rate Elastomeric Pumps: Adjustable Flow Rate Elastomeric Pumps, Pumps With Programmable Infusion Rates, Multi-therapy Variable Rate Elastomeric Pumps, Infusion Pumps For Chemotherapy And High-Precision Treatments

What Are The Drivers Of The Elastomeric Infusion Pumps Market?

The growing rate of hospitalized patients is expected to propel the growth of the elastomeric infusion pump market going forward. Hospitalized patients are people who are admitted to a hospital for medical treatment and care, which require ongoing monitoring and specific interventions. Advances in medical technology have made more complex and effective treatments available, leading to increased hospital admissions for surgeries and procedures. Elastomeric infusion pumps allow patients to continue receiving necessary medications, such as antibiotics, pain management, or chemotherapy, at home rather than in the hospital. This enables early discharge, freeing up hospital beds for other patients and reducing hospital occupancy rates. For instance, in December2024, according to a report published by the National Health Service (NHS), a UK-based government department, there were 552,592 emergency admissions in the month, representing a 1.2% increase compared to December 2023. Therefore, the growing rate of hospitalized patients will drive the elastomeric infusion pump industry. The rising healthcare expenditure is expected to propel the growth of the elastomeric infusion pumps market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Rising healthcare expenditure supports the adoption of elastomeric infusion pumps by enabling hospitals and home-care providers to invest in advanced devices, access specialty therapies, and ensure proper training and maintenance. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the elastomeric infusion pumps industry.

Key Players In The Global Elastomeric Infusion Pumps Market

Major companies operating in the elastomeric infusion pumps market are Baxter International Inc., Medline Industries, B. Braun Melsungen AG, Nipro Corporation, Avanos Medical Inc., Vygon SAS, pfm medical gmbh, Integrated Medical Systems Inc., Preferred Medical, Leventon S.A.U, Tuoren Medical, Eitan Medical, PROMECON GmbH, Epic Medical, Promecon Medical, Ace Medical Devices, Gamastech, Adria Med, Heka Healthcare, Beijing KellyMed Co. Ltd

What Are Latest Mergers And Acquisitions In The Elastomeric Infusion Pumps Market?

In December 2024, Nipro Trading (Shanghai) Co., Ltd., a Japan-based medical device company, acquired Sichuan Pure Science and Technology Co., Ltd., for an undisclosed amount. With this acquisition, Nipro Trading aims to strengthen its dialysis solutions portfolio, enhance supply chain capabilities, expand its presence in the Chinese dialysis equipment market, and improve long-term service offerings and operational efficiency. Sichuan Pure Science and Technology Co., Ltd. is a China-based medical device company that offers elastomeric infusion pumps.

Regional Outlook

North America was the largest region in the elastomeric infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Elastomeric Infusion Pumps Market?

The elastomeric infusion pumps market consists of sales of tubing sets, medication reservoirs, filters, needles and catheters, connectors, and adaptors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.